(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-6.31% € 115.85
Live Chart Being Loaded With Signals
Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature...
Stats | |
---|---|
Dagens volum | 77.00 |
Gjennomsnittsvolum | 478.00 |
Markedsverdi | 23.94B |
EPS | €0 ( 2023-09-30 ) |
Last Dividend | €5.00 ( 2023-05-15 ) |
Next Dividend | €0 ( N/A ) |
P/E | 38.75 |
ATR14 | €0 (0.00%) |
Coloplast A/S Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Coloplast A/S Økonomi
Annual | 2023 |
Omsetning: | €24.50B |
Bruttogevinst: | €16.33B (66.64 %) |
EPS: | €22.21 |
FY | 2023 |
Omsetning: | €24.50B |
Bruttogevinst: | €16.33B (66.64 %) |
EPS: | €22.21 |
FY | 2022 |
Omsetning: | €22.58B |
Bruttogevinst: | €15.53B (68.78 %) |
EPS: | €22.14 |
FY | 2021 |
Omsetning: | €19.43B |
Bruttogevinst: | €13.31B (68.53 %) |
EPS: | €22.70 |
Financial Reports:
No articles found.
Coloplast A/S Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€15.00 (N/A) |
€0 (N/A) |
€5.00 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €1.800 | 2007-12-19 |
Last Dividend | €5.00 | 2023-05-15 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 27 | -- |
Total Paid Out | €171.20 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.1 | -- |
Div. Sustainability Score | 8.24 | |
Div.Growth Potential Score | 3.98 | |
Div. Directional Score | 6.11 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
O2D.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
AIY.DE | Ex Dividend Junior | 2023-08-01 | Sporadic | 0 | 0.00% | |
H5E.DE | No Dividend Player | 2023-07-10 | Annually | 0 | 0.00% | |
RAA.DE | Ex Dividend Knight | 2023-05-11 | Annually | 0 | 0.00% | |
BPFG.F | Ex Dividend Junior | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
ITU.DE | Ex Dividend Knight | 2023-10-06 | Quarterly | 0 | 0.00% | |
SYT.DE | Ex Dividend Junior | 2023-05-05 | Annually | 0 | 0.00% | |
DAR.DE | No Dividend Player | 2023-07-03 | Annually | 0 | 0.00% | |
M4N.DE | Ex Dividend Junior | 2023-06-07 | Sporadic | 0 | 0.00% | |
3T70.F | Ex Dividend Knight | 2023-08-31 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.194 | 1.500 | 6.11 | 9.17 | [0 - 0.5] |
returnOnAssetsTTM | 0.100 | 1.200 | 6.66 | 7.99 | [0 - 0.3] |
returnOnEquityTTM | 0.429 | 1.500 | 6.35 | 9.52 | [0.1 - 1] |
payoutRatioTTM | 1.175 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 0.532 | 0.800 | -2.34 | -1.871 | [1 - 3] |
quickRatioTTM | 0.281 | 0.800 | -3.06 | -2.44 | [0.8 - 2.5] |
cashRatioTTM | 0.0484 | 1.500 | -0.842 | -1.263 | [0.2 - 2] |
debtRatioTTM | 0.445 | -1.500 | 2.58 | -3.87 | [0 - 0.6] |
interestCoverageTTM | 10.72 | 1.000 | 7.14 | 7.14 | [3 - 30] |
operatingCashFlowPerShareTTM | 27.49 | 2.00 | 0.836 | 1.672 | [0 - 30] |
freeCashFlowPerShareTTM | 21.81 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.430 | -1.500 | 4.28 | -6.42 | [0 - 2.5] |
grossProfitMarginTTM | 0.666 | 1.000 | 2.23 | 2.23 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.275 | 1.000 | 6.49 | 6.49 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.278 | 1.000 | 9.57 | 9.57 | [0.2 - 2] |
assetTurnoverTTM | 0.515 | 0.800 | 9.90 | 7.92 | [0.5 - 2] |
Total Score | 8.24 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.78 | 1.000 | 6.18 | 0 | [1 - 100] |
returnOnEquityTTM | 0.429 | 2.50 | 7.65 | 9.52 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 21.81 | 2.00 | 2.73 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.43 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 27.49 | 2.00 | 0.836 | 1.672 | [0 - 30] |
payoutRatioTTM | 1.175 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -2.22 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.240 | 1.000 | 6.50 | 0 | [0.1 - 0.5] |
Total Score | 3.98 |
Coloplast A/S
Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.